Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin V Grimes

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Journal of Molecular and Cellular Cardiology|May 19, 2020
p38 MAPK inhibition: A promising therapeutic approach for COVID-19Joseph M Grimes, Kevin V Grimes
Nature Reviews. Drug Discovery|December 1, 2012
Protein kinase C, an elusive therapeutic target?Daria Mochly-Rosen, Kanad Das, Kevin V Grimes
Journal of Clinical and Translational Science|April 18, 2022
Preventive drugs for Huntington's disease: A choice-based conjoint survey of patient preferencesMarcus C Parrish, Andrea Hanson-Kahn, V Srinivasan, et al.
Clinical Therapeutics|February 4, 2020
A Qualitative Study on the Differences Between Trial Populations and the Approved Therapeutic Indications of Antineoplastic Agents by 3 Regulatory Agencies From 2010 to 2018Eriko Sumi, Ryuta Asada, Ying Lu, et al.
Annual Review of Pharmacology and Toxicology|September 13, 2018
Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug DiscoveriesMarcus C Parrish, Yuan Jin Tan, Kevin V Grimes, et al.
Journal of Neuropathology and Experimental Neurology|May 6, 2022
Azetidine-2-Carboxylic Acid-Induced Oligodendrogliopathy: Relevance to the Pathogenesis of Multiple SclerosisRaymond A Sobel, Megan Albertelli, Julian R Hinojoza, et al.
Cancer Management and Research|February 23, 2026
A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case ReportTinashe Adrian Mazhindu, Zedias Chikwambi, Edith Matsikidze, et al.
BMJ Open Gastroenterology|December 31, 2021
Treatment-refractory ulcerative colitis responsive to indigo naturalisJulie P Saiki, Johan Ol Andreasson, Kevin V Grimes, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 9, 2023
An electronic health record cohort of Veterans with amyotrophic lateral sclerosisRichard J Reimer, Andre Goncalves, Braden Soper, et al.
The Lancet. Digital Health|March 11, 2026
Identification of drug repurposing candidates for amyotrophic lateral sclerosis using electronic health records: a retrospective cohort studyRichard J Reimer, Braden Soper, Jennifer L Wilson, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Journal of Molecular and Cellular Cardiology|May 19, 2020
p38 MAPK inhibition: A promising therapeutic approach for COVID-19Joseph M Grimes, Kevin V Grimes
Nature Reviews. Drug Discovery|December 1, 2012
Protein kinase C, an elusive therapeutic target?Daria Mochly-Rosen, Kanad Das, Kevin V Grimes
Journal of Clinical and Translational Science|April 18, 2022
Preventive drugs for Huntington's disease: A choice-based conjoint survey of patient preferencesMarcus C Parrish, Andrea Hanson-Kahn, V Srinivasan, et al.
Clinical Therapeutics|February 4, 2020
A Qualitative Study on the Differences Between Trial Populations and the Approved Therapeutic Indications of Antineoplastic Agents by 3 Regulatory Agencies From 2010 to 2018Eriko Sumi, Ryuta Asada, Ying Lu, et al.
Annual Review of Pharmacology and Toxicology|September 13, 2018
Surviving in the Valley of Death: Opportunities and Challenges in Translating Academic Drug DiscoveriesMarcus C Parrish, Yuan Jin Tan, Kevin V Grimes, et al.
Journal of Neuropathology and Experimental Neurology|May 6, 2022
Azetidine-2-Carboxylic Acid-Induced Oligodendrogliopathy: Relevance to the Pathogenesis of Multiple SclerosisRaymond A Sobel, Megan Albertelli, Julian R Hinojoza, et al.
Cancer Management and Research|February 23, 2026
A Pharmacogenomic Basis for Tolerance of 5-Fluorouracil Following Early, Severe Toxicity from Capecitabine in a CDA Ultrarapid Metabolizer Colon Cancer Patient: A Case ReportTinashe Adrian Mazhindu, Zedias Chikwambi, Edith Matsikidze, et al.
BMJ Open Gastroenterology|December 31, 2021
Treatment-refractory ulcerative colitis responsive to indigo naturalisJulie P Saiki, Johan Ol Andreasson, Kevin V Grimes, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|August 9, 2023
An electronic health record cohort of Veterans with amyotrophic lateral sclerosisRichard J Reimer, Andre Goncalves, Braden Soper, et al.
The Lancet. Digital Health|March 11, 2026
Identification of drug repurposing candidates for amyotrophic lateral sclerosis using electronic health records: a retrospective cohort studyRichard J Reimer, Braden Soper, Jennifer L Wilson, et al.
Pageof 2